Clinical Trial Update: Evaluation of NV701 (Pilocarpine 1.25%) Compared With Vuity (Pilocarpine 1.25%) on Pupil Size in Subjects With Presbyopia [EARLY_Phase 1]

View source ↗

Summary

An early phase 1 trial comparing NV701 (pilocarpine 1.25%) with Vuity (pilocarpine 1.25%) on pupil size in people with presbyopia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• NV701 (pilocarpine)
• Vuity (pilocarpine)

Snippet

Sponsor: Novus Vision LLC | Conditions: Pupil Constriction | EARLY_Phase 1 | Status: COMPLETED